COVID-19 Funding Opportunities

The Office of Research and Innovation (VCRI) is tracking funding opportunities relating to COVID-19. Identified opportunities will be posted here regularly. (Last updated 7/20/2020)

Deadline Program Funding Amount Sponsor
Rolling NIH POCTRN - Fast-Track Program for COVID-19 Test Development and Distribution - Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing Up to $500 million available in total awards National Institutes of Health (NIH)
Varies Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) Variable National Institutes of Health (NIH)
3/27/2020 (applications accepted through 4/15/2021) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus Variable National Institutes of Health (NIH)
4/5/2020 (application deadlines through 4/5/2021) Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Variable National Institute of Allergy and Infectious Diseases (NIAID)
4/6/2020 (applications accepted through 5/1/2021) Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
Variable
National Institutes of Health (NIH)
4/13/2020 (applications accepted until 3/31/2021) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
$200,000 (direct costs)
National Institutes of Health (NIH)
4/30/2020 (Applications accepted until 8/14/2020) Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
Budgets must reflect the actual needs
National Institutes of Health (NIH)
5/1/2020 (applications accepted through 10/5/2020) Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials Up to two years of support National Institutes of Health (NIH)
5/1/2020 (applications accepted through 5/1/2021) Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities $125,000 (direct costs) National Institutes of Health (NIH)
5/4/2020 (applications accepted until 11/10/2020) Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs Variable National Institutes of Health (NIH)
Multiple (e.g. 5/13/2020; 9/13/2020; etc.) Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)  Not limited National Institutes of Health (NIH)
5/15/2020(applications accepted until 4/15/2021) Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA $200,000 (direct costs) National Institutes of Health (NIH)
5/15/2020 (applications accepted until 1/25/2022) Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus Variable National Institutes of Health (NIH)
5/15/2020 (applications accepted until 1/25/2022) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to no more than 25% total costs of the amount of the current parent award National Institutes of Health (NIH)
6/12/2020 (Phase I)
8/18/2020 (Phase II)
Emergency Response for the Health Care System: Phase I Unspecified Robert Wood Johnson Foundation (RWJF)
6/12/2020 (Phase I)
8/18/2020 (Phase II)
Emergency Response for the General Public Innovation Challenge Unspecified Robert Wood Johnson Foundation (RWJF)
7/1/2020 (First available due date; dates through  2/1/2021) NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Unspecified Department of Health and Human Services (DHHS)
7/13/2020 (Rolling) Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) $25M total funding available. Department of Health and Human Services (DHHS)
7/31/2020 2020 COVID-19 Call for Code Global Challenge $270,000 XPRIZE
9/9/2020 Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) $275,000 (direct costs) National Institutes of Health (NIH)
9/30/2020 ND-NOFO-20-111: COVID-19 Small Grants Program $100,000 Department of State (DOS)
9/30/2020 CSO COVID-19 Response Varies Department of Defense (DOD)
10/5/2020 (and standard R01 deadlines) Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Not limited National Institutes of Health (NIH)
10/5/2020 (Rolling)  Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Not limited National Institutes of Health (NIH)
10/31/2020 Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Negotiated after white paper stage Biomedical Advanced Research and Development Authority (BARDA)
11/10/2020 (Rolling) Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) Up to two years of support- limited to no more than the amount of the current parent award National Institutes of Health (NIH)
12/01/2020 Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) $500,000 Department of Health and Human Services (DHHS)
2/6/2021 (Rolling) Administrative Supplement Not limited National Institutes of Health (NIH)
2/6/2021 (Rolling) Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 Not limited National Institutes of Health (NIH)
3/31/2021 (Rolling) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus $100K direct costs/year National Institutes of Health (NIH)
4/14/2021 Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System $200,000 (direct costs) National Institutes of Health (NIH)
8/14/2020 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) $275,000 (direct costs) 4/30/2020 (Applications accepted until 4/30/2021)
Rolling Research Grant for Pandemic Preparedness 1,500,000 € Merck KGaA (Germany)
Rolling COVID-19 Solutions Fund $50,000 Mozilla
Rolling Invitation for COVID-19 scientific questions DOE Resources Department of Energy (DOE)
Rolling Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Variable National Institute of Allergy and Infectious Diseases (NIAID)
See Emergency Notice of Special Interest by IC Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) Not limited National Institutes of Health (NIH)
Check with program officers RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 National Science Foundation (NSF)
Check with program officers Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) $200,000 (RAPID) & supplemental funding requests National Science Foundation (NSF)
Rolling Blue  & You Foundation Covid Grants Program $5,000 to $150,000 Blue Cross and Blue Shield Association
Rolling Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to no more than 25% total costs of the amount of the current parent award National Institutes of Health (NIH)
Rolling Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus Contact program officer. National Institutes of Health (NIH)
Rolling Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) Variable National Institutes of Health (NIH)
Rolling  Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) Variable National Institutes for Health (NIH)
Rolling COVID-19 Open Research Dataset Challenge (CORD-19) $1,000 per-task award Kaggle
Rolling AWS Diagnostic Development Initiative (DDI) $20,000,000 (total amount of credits and support available) Amazon Web Services (AWS)
Rolling Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 Variable National Institute of General Medical Sciences (NIGMS)
Rolling National Emergency Telecritical Care Network (NETCCN) Project for Coronavirus $30 to $37 Million (M) in FY20 funds, contingent on the availability of funds Medical Technology Enterprise Consortium (MTEC)
Rolling Open Call for Innovation Focus Area: COVID-19: Rapid Sanitising Technology Not specified Defence and Security Accelerator (DASA)
Rolling COVID-19 Fast Track Access Access to selected instruments for research related to the COVID-19, without the necessity to undergo the regular evaluation procedure Central European Research Infrastructure Consortium (CERIC)
Anticipated Presolicitation: Prototype Development to Combat Novel Coronavirus Disease COVID-19 TBD Medical Technology Enterprise Consortium (MTEC)
Anticipated New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 TBD Agency for Healthcare Research and Quality (AHRQ)